1 |
Pouton, C.W., 2000. Lipid Formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. 11, S93-S98.
DOI
ScienceOn
|
2 |
Sarciaux, J.M., Acar, L., Sado, P.A., 1995. Using microemulsion Formulations for drug delivery of therapeutic peptides. Int. J. Pharm. 120, 127-136.
DOI
|
3 |
Schulman, J.H., Montagne, J.B., 1961. Formation of microemulsions by amino alkyl alcohols. Ann. N. Y. Acad. Sci. 92, 366-371.
DOI
|
4 |
Schulman, J.H., Stoekenius, W., Prince, L., M. J., 1959. Mechanism of formation and structure of microemulsions by electron microscopy. Phys. Chem., 63, 1677-1678.
DOI
|
5 |
Shah, N.H., Carvajal, M.T., Patel, C.I., Infeld, M.H., Malick, A.W., 1994. Selfemulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 106, 15-23.
DOI
|
6 |
Torrado, S., L’opez, M.L., Torrado, G., Bol’as, F., Torrado, S., Cad’orniga, R., 1997. A novel Formulation of albendazole solution: oral bioavailability and efficacy evaluation. Int. J. Pharm., 156, 181-187.
DOI
|
7 |
Vogt, M., Kunath, K., Dressman, J.B., 2008. Dissolution enhacement of fenofibrate by microniziation, cogrinding and proaydrying: Comparison with commercial preparations. Eur. J. Pharm. Biopharm. 68, 283-288.
DOI
|
8 |
Kasim, N.A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernas, H., Hussain, A.S., Junginger, H.E., Stavchansky, S.A., Midha, K.K., Shah, V.P., Amidon, G.L., 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 1, 85-96.
DOI
|
9 |
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., Masuda, K., 2002. Microemulsion Formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control. Release. 81, 65-74.
DOI
|
10 |
Keck, C.M., Muller, R.H, 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur. J. Pharm. Bio. 62, 3-16
DOI
|
11 |
Kim., K.H., Rhee., Y.S., Bae, J.H., Chi, S.C., Park, E.S., 1999. Improvement of Dissolution Rate of Poorly Water Soluble Drug Using Self-microemulsifying Drug Delivery System. J. Kor. Pharm. Sci. 29, 37-45.
과학기술학회마을
|
12 |
Najib, J., 2002. Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet Formulation. Clin Ther. 24, 2022-2050.
DOI
|
13 |
Kreuter, J. (Ed.), 1994. Colloidal Drug Delivery Systems. Marcel Dekker, New York, 31-65.
|
14 |
Law, D., Wang, W., Schmitt, E., Qiu, Y., Krill, S.K., Fort, J.J., 2003. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J. Pharm. Sci. 92, 505-515.
DOI
|
15 |
Mayer, D., 1988. Surfactant Science and Technology. VCH Publishers, Inc., 174-175.
|
16 |
Patel, A.R., Vavia, P.R., 2006. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J. Incl. Phenom. Macrocycl. Chem. 56, 247-251.
DOI
|
17 |
Physician’s Desk Reference 2000. 54th ed. Montvale, NJ:Medical Economics Company, 476-477.
|
18 |
Charman, SA., Charman, WN., Rogge, MC., Wilson, TD., Dutko, FJ., Pouton, CW., 1992. Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 9, 87-93.
DOI
|
19 |
Constantinides, PP., 1995. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 12, 1561-1572.
DOI
|
20 |
Curtet, B., Teillaud, E., Reginault, P., inventors., 1980. Fournier Innovation et Synergie, assignee. Novel dosage form of fenofibrate. US patent 4895726. January 23.
|
21 |
Danielsson, I., Lindman, B., 1981. The definition of a microemulsion, Colloids and Surfaces. 3, 391-392.
DOI
|
22 |
Hanafy, A., Spahn-Langguth, H., Vergnault, G., Grenier, P., Tubic Grozdanis, M., Lenhardt, T., Langguth, P., 2007. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv. Drug Deliv. Rev. 59, 419-426.
DOI
|
23 |
Georgakopoulos, E., Farah, N., Vergnault, G., 1992-93. Oral anhydrous nonionic microemulsions administrated in softgel capsules. Gattefosse, B.T., 85, 11-20.
|
24 |
Gershanik, T., Benzeno, S., Benita, S., 1998. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res. 15, 863-869.
DOI
|
25 |
Groves, M.J., de Galindez, D.A., 1976. The self-emulsifying action of mixed surfactants in oil. Acta. Pharm. Suec. 13, 361-372.
|
26 |
Kim., H.J., Yoon., K.A., Hahn, M.K., Park, E.S., Chi, S.C., 2000. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 26, 523-529.
DOI
|
27 |
Kang, B.K., Lee, J.S., C, S.K., Jeong, S.Y., Yuk, S.H., Khang., G.S., Lee, H.B., Cho, S.H., 2004. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 274, 65-73.
DOI
ScienceOn
|